1 not yet recruiting, 1 terminated, 1 unknown. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Not yet recruiting 1, Terminated 1, Unknown 1 |
Follow ORMD-0801: new trials by email Literature Review of ORMD-0801 trials Research Report on ORMD-0801
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus. ORMD-0801 8 mg, Placebo capsule, ORMD-0801 16 mg - Type 2 Diabetes Mellitus | Phase 3 | Not yet recruiting | Oramed, Ltd. | 300 | 2025-12-15 | 2025-08-03 |
| Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus ORMD-0801 - Diabetes Mellitus, Type 2 | Phase 3 | Unknown | King Hamad University Hospital, Bahrain | 608 | 2021-10-01 | 2021-03-26 |
| A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus ORMD-0801, Placebo - T2DM (Type 2 Diabetes Mellitus) | Phase 3 | Terminated | Oramed, Ltd. | 346 | 2021-03-16 | 2023-02-09 |
Oramed, Ltd. (2) · King Hamad University Hospital, Bahrain (1)
United States (2)
Dr. Dalal Alromaihi (1) · Miriam Kidron, Ph.D. (1) · Miriam Kidron, PhD (1)